Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function.
Bedin M, Boyer O, Servais A, Li Y, Villoing-Gaudé L, Tête MJ, Cambier A, Hogan J, Baudouin V, Krid S, Bensman A, Lammens F, Louillet F, Ranchin B, Vigneau C, Bouteau I, Isnard-Bagnis C, Mache CJ, Schäfer T, Pape L, Gödel M, Huber TB, Benz M, Klaus G, Hansen M, Latta K, Gribouval O, Morinière V, Tournant C, Grohmann M, Kuhn E, Wagner T, Bole-Feysot C, Jabot-Hanin F, Nitschké P, Ahluwalia TS, Köttgen A, Andersen CBF, Bergmann C, Antignac C, Simons M. Bedin M, et al. J Clin Invest. 2020 Jan 2;130(1):335-344. doi: 10.1172/JCI129937. J Clin Invest. 2020. PMID: 31613795 Free PMC article. Clinical Trial.
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal function.
Bedin M, Boyer O, Servais A, Li Y, Villoing-Gaudé L, Tête MJ, Cambier A, Hogan J, Baudouin V, Krid S, Bensman A, Lammens F, Louillet F, Ranchin B, Vigneau C, Bouteau I, Isnard-Bagnis C, Mache CJ, Schäfer T, Pape L, Gödel M, Huber TB, Benz M, Klaus G, Hansen M, Latta K, Gribouval O, Morinière V, Tournant C, Grohmann M, Kuhn E, Wagner T, Bole-Feysot C, Jabot-Hanin F, Nitschké P, Ahluwalia TS, Köttgen A, Andersen CBF, Bergmann C, Antignac C, Simons M. Bedin M, et al. Among authors: isnard bagnis c. J Clin Invest. 2022 Jun 1;132(11):e161852. doi: 10.1172/JCI161852. J Clin Invest. 2022. PMID: 35642643 Free PMC article. No abstract available.
"Doctor, can I have less frequent injection with highly efficient treatment?" A patient centered study using an electronic choice-based conjoint analysis (ePRO) to assess real world preferences regarding erythropoiesis stimulating agent to treat anaemia in chronic kidney disease (PERCEPOLIS study).
Vigneau C, Choukroun G, Isnard-Bagnis C, Pau D, Sinnasse-Raymond G, Pibre S, Moranne O. Vigneau C, et al. Nephrol Ther. 2019 Jun;15(3):152-161. doi: 10.1016/j.nephro.2018.11.009. Epub 2019 Apr 5. Nephrol Ther. 2019. PMID: 30962139
Tubular transporters and clearance of adefovir.
Servais A, Lechat P, Zahr N, Urien S, Aymard G, Jaudon MC, Deray G, Isnard Bagnis C. Servais A, et al. Eur J Pharmacol. 2006 Jul 1;540(1-3):168-74. doi: 10.1016/j.ejphar.2006.04.047. Epub 2006 May 6. Eur J Pharmacol. 2006. PMID: 16756973
Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C, Jidar K, Walker-Combrouze F, Peraldi MN, Isnard-Bagnis C, Servais A, Lortholary O, Noël LH, Bollée G. Bigé N, et al. Nephrol Dial Transplant. 2012 Mar;27(3):1114-21. doi: 10.1093/ndt/gfr376. Epub 2011 Jul 10. Nephrol Dial Transplant. 2012. PMID: 21745806
[QuiPO: who inject EPO?].
Vigneau C, Le Stum S, Isnard-Bagnis C, Choukroun G, Lemeur Y, Kamar N, Oger E. Vigneau C, et al. Nephrol Ther. 2014 Dec;10(7):507-11. doi: 10.1016/j.nephro.2014.06.003. Epub 2014 Oct 22. Nephrol Ther. 2014. PMID: 25439107 French.
[Tubular transporters OAT1 and MRP2 and clearance of adefovir].
Servais A, Lechat P, Zahr N, Urien S, Aymard G, Jaudon MC, Deray G, Isnard Bagnis C. Servais A, et al. Nephrol Ther. 2005 Nov;1(5):296-300. doi: 10.1016/j.nephro.2005.06.011. Epub 2005 Oct 21. Nephrol Ther. 2005. PMID: 16895698 French.
80 results